|
🐬
|
Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study
E. Bruckert,
G. Hayem,
S. Dejager,
C. Yau,
B. Bégaud
|
10 |
2005 |
10
🐬
|
|
🐢
|
Anakinra for severe forms of COVID-19: a cohort study
17 auth.
T. Huet,
H. Beaussier,
Olivier Voisin,
S. Jouveshomme,
G. Dauriat,
I. Lazareth,
Emmanuelle Sacco,
J. Naccache,
Y. Bézie,
S. Laplanche,
...
A. Le Berre,
J. Le Pavec,
S. Salmerón,
J. Emmerich,
J. Mourad,
G. Chatellier,
G. Hayem
|
9 |
2020 |
9
🐢
|
|
🐜
|
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
14 auth.
X. Mariette,
P. Ravaud,
S. Steinfeld,
G. Baron,
J. Goetz,
E. Hachulla,
B. Combe,
X. Puéchal,
Y. Pennec,
B. Sauvezie,
...
A. Perdriger,
G. Hayem,
A. Janin,
J. Sibilia
|
8 |
2004 |
8
🐜
|
|
🦁
|
SAPHO syndrome: a long-term follow-up study of 120 cases.
8 auth.
G. Hayem,
A. Bouchaud-Chabot,
K. Benali,
S. Roux,
E. Palazzo,
O. Silbermann-Hoffman,
...
M. Kahn,
O. Meyer
|
8 |
1999 |
8
🦁
|
|
🐜
|
European multicentre study to define disease activity criteria for systemic sclerosis.* II. Identification of disease activity variables and development of preliminary activity indexes
26 auth.
G. Valentini,
A. D. Rossa,
S. Bombardieri,
W. Bencivelli,
A. Silman,
S. d'Angelo,
M. Cerinic,
J. J. Belch,
C. Black,
P. Bruhlmann,
L. Czirják,
A. D. Luca,
A. Drosos,
C. Ferri,
A. Gabrielli,
...
R. Giacomelli,
G. Hayem,
M. Inanç,
N. McHugh,
H. Nielsen,
M. Rosada,
Raffaella Scorza,
J. Štork,
A. Sysa,
F. V. D. Hoogen,
P. Vlachoyiannopoulos
|
8 |
2001 |
8
🐜
|
|
🐜
|
Treatment of Primary Sjgren Syndrome With Rituximab
20 auth.
V. Devauchelle-pensec,
X. Mariette,
S. Jousse-Joulin,
J. Berthelot,
A. Perdriger,
Xavier Puchal,
Vronique Le Guern,
J. Sibilia,
J. Gottenberg,
L. Chiche,
...
E. Hachulla,
P. Hatron,
V. Goeb,
G. Hayem,
J. Morel,
C. Zarnitsky,
J. Dubost,
J. Pers,
E. Nowak,
A. Saraux
|
8 |
2014 |
8
🐜
|
|
🐜
|
A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites.
10 auth.
P. M. Dang,
A. Stensballe,
Tarek Boussetta,
Houssam Raad,
Cédric Dewas,
Y. Kroviarski,
...
G. Hayem,
O. Jensen,
M. Gougerot-Pocidalo,
J. El-Benna
|
8 |
2006 |
8
🐜
|
|
🐜
|
Vasculitides associated with malignancies: analysis of sixty patients.
31 auth.
O. Fain,
M. Hamidou,
P. Cacoub,
B. Godeau,
B. Wechsler,
J. Pariés,
J. Stirnemann,
A. Morin,
M. Gatfossé,
T. Hanslik,
N. Belmatoug,
O. Blétry,
R. Cevallos,
I. Delévaux,
E. Fisher,
...
G. Hayem,
G. Kaplan,
C. Le Hello,
L. Mouthon,
C. Larroche,
V. Lemaire,
A. Piette,
J. Piette,
T. Ponge,
X. Puéchal,
J. Rossert,
F. Sarrot-Reynauld,
D. Sicard,
J. Ziza,
M. Kahn,
L. Guillevin
|
8 |
2007 |
8
🐜
|
|
🐜
|
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial.
23 auth.
J. Gottenberg,
P. Ravaud,
X. Puéchal,
V. le Guern,
J. Sibilia,
V. Goeb,
C. Larroche,
J. Dubost,
S. Rist,
A. Saraux,
...
V. Devauchelle-Pensec,
J. Morel,
G. Hayem,
P. Hatron,
A. Perdriger,
D. Sène,
C. Zarnitsky,
D. Batouche,
V. Furlan,
J. Bénessiano,
É. Perrodeau,
R. Seror,
X. Mariette
|
8 |
2014 |
8
🐜
|
|
🐜
|
Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases.
10 auth.
L. Sarda,
A. Crémieux,
Y. Lebellec,
A. Meulemans,
R. Lebtahi,
G. Hayem,
...
R. Génin,
N. Delahaye,
D. Huten,
D. Le Guludec
|
7 |
2003 |
7
🐜
|
|
🐢
|
Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.
7 auth.
M. Hurtado-Nedelec,
S. Chollet-Martin,
P. Nicaise-Roland,
S. Grootenboer‐Mignot,
R. Ruimy,
O. Meyer,
...
G. Hayem
|
7 |
2008 |
7
🐢
|
|
🦁
|
Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis.
11 auth.
G. Hayem,
P. Chazerain,
B. Combe,
A. Elias,
T. Haim,
P. Nicaise,
...
K. Benali,
J. Eliaou,
Kahn Mf,
J. Sany,
O. Meyer
|
7 |
1999 |
7
🦁
|
